Search clinical trials for: opioid substitution settings

Total 7375 results

Kirby Institute
National Health and Medical Research Council, Australia

Recruiting

ETHOS ENGAGE: Enhancing Treatment of Hepatitis C in Opioid Substitution Settings (ETHOS II)

Hepatitis C

Australia
Howard University
National Institute on Drug Abuse (NIDA); University of Miami; University of Illinois... and other collaborators

Not yet recruiting

Integrating MOUD in African American Community Settings (Better Together)

Opioid Use Disorder

United States
Yih-Ing Hser
National Institute on Drug Abuse (NIDA); University of California, Los Angeles and other collaborators

Not yet recruiting

Extended-release Buprenorphine Compared to Sublingual Buprenorphine in Rural Settings (RXR) (RXR)

Substance-Related Disorders | Opioid-Related Disorders | Narcotic-Related Disorders

United States
Johns Hopkins University
Pear Therapeutics, Inc.

Terminated

Pilot Study of reSET-O to Treatment-as-usual in Acute Care Settings

Opioid-use Disorder

United States
Steve N. Caritis, MD
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Terminated

Pharmacologically-based Strategies for Opioid Substitution Therapy During Pregnancy

Pregnancy | Opiate Addiction

United States
University of Pittsburgh

Completed

Impact of Pregnancy on Buprenorphine Pharmacokinetics and Pharmacodynamics

Pregnancy | Opiate Addiction

United States
April M Young
National Institute on Drug Abuse (NIDA)

Active, not recruiting

Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk

Sexually Transmitted Diseases | Opioid-Related Disorders | Substance Abuse | Drug Overdose | Opiate Substitution Treatment | Human Immunodeficiency Virus (HIV) | Hepatitis C (HCV) | Intravenous Drug Usage

United States
University of Arkansas

Enrolling by invitation

Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder

Opioid-Related Disorders | Magnetic Resonance Imaging | Mobile Applications | Opiate Substitution Treatment | Craving | Attentional Bias | Ecological Momentary Assessment

United States
Yale University
National Institute on Drug Abuse (NIDA); University of Malaya

Active, not recruiting

Addiction, HIV and Tuberculosis in Malaysian Criminal Justice Settings (HARAPAN II)

Hepatitis | HIV/AIDS | Tuberculosis | Addiction | Opioid Dependence

Malaysia
Boston University
National Institute on Drug Abuse (NIDA)

Active, not recruiting

Treating Chronic Pain in Buprenorphine Patients in Primary Care Settings (TOPPS)

Opioid-Related Disorders

United States
Trustees of Dartmouth College
Patient-Centered Outcomes Research Institute

Completed

MOms in REcovery (MORE) Study: Defining Optimal Care (MORE)

Opioid-Related Disorders | Substance Use Disorders | NAS

United States
HealthPartners Institute
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC; Geisinger Clinic and other collaborators

Completed

Clinical Decision Support for Opioid Use Disorders in Medical Settings (COMPUTE 2.0)

Opioid-use Disorder

United States
Milton S. Hershey Medical Center
National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)

Completed

Use of a GLP-1R Agonist to Treat Opioid Use Disorder

Opioid-Related Disorders | Opiate Substitution Treatment

United States
King's College London
NHS Tayside; Bangor University; South London and Maudsley NHS Foundation Trust; Greater Manchester Mental Health NHS Foundation Trust and other collaborators

Completed

Extended-release Pharmacotherapy for Opioid Use Disorder (EXPO)

Opiate Substitution Treatment

United Kingdom
Denver Health and Hospital Authority
Department of Health and Human Services

Active, not recruiting

Increasing Linkage to Family Planning Care for Individuals With Substance Use Disorder

Substance-Related Disorders | Opiate Substitution Treatment | Family Planning Services | Sexual Health

United States
Haukeland University Hospital
University of Bergen; Helse Stavanger HF; Helse Vest; Forskningsrådet; Folkehelse... and other collaborators

Active, not recruiting

Integrated Treatment of Hepatitis C Virus Infection (INTRO-HCV)

Hepatitis C, Chronic | Opioid Dependence, on Agonist Therapy

Norway
Haukeland University Hospital
University of Bergen; Helse Stavanger HF; Helse Vest

Active, not recruiting

Integrated Exercise Program in Opioid Agonist Therapy Clinics (BAReAktiv)

Substance-Related Disorders

Norway
Haukeland University Hospital
University of Oslo; University of Bergen; Helse Stavanger HF; Helse Vest; ProLAR...

Active, not recruiting

Effect of Fruit Smoothie Supplementation on Psychological Distress Among People Receiving Opioid Agonist Therapy (FruktBAR)

Substance-Related Disorders

Norway
Haukeland University Hospital
University of Bergen; Helse Stavanger HF; Helse Vest

Active, not recruiting

Easy Access to Smoking Cessation for People Receiving Opioid Agonist Therapy Who Are Smoking Tobacco (BAReNikotin)

Substance-Related Disorders | Smoking Cessation

Norway
University of Michigan
National Institute on Drug Abuse (NIDA)

Completed

Default Dosing Settings for Opioid Prescriptions to Adolescents and Young Adults After Tonsillectomy

Tonsillectomy

United States
University of Maryland, Baltimore

Active, not recruiting

Hepatitis C Treatment to Prevent HIV, Initiate Opioid Substitution Therapy, and Reduce Risky Behavior (ANCHOR)

HCV | Burpenorphine | PreP

United States
Nantes University Hospital
CSAPA Apsyades; OPPELIA-Le triangle

Completed

Treatment for Opiate Addiction: Prognostic fActors of Responsiveness to Maintenance Treatment (TOPAZE)

Opioid-use Disorder

France
Lifespan
The Miriam Hospital; University of Rhode Island

Active, not recruiting

Medication Maintenance Therapy in Community Pharmacy Settings (MATPharm)

Opioid-use Disorder

United States
National Opinion Research Center
Merck Sharp & Dohme LLC; Emory University; Grady Health System

Terminated

Registry-based HCV Care Cascade Navigation at Atlanta's Grady Memorial Hospital (EZ-C)

Hepatitis C

United States
MetroHealth Medical Center

Completed

ICE T for Post GYN Surgery Pain

Opioid Substitution Treatment

United States
McMaster University

Terminated

Routine Pregnancy Screening for Women on Opioid Substitution Therapy (PREG-O)

Substance Use Disorders | Pregnancy Outcome | Prenatal Care

Canada
M. Eugenia Socias
Canadian Institutes of Health Research (CIHR); Mayne Pharma International Pty... and other collaborators

Terminated

Slow-Release Oral Morphine for the Treatment of Opioid Use Disorder (pRESTO)

Opioid-Related Disorders | Opiate Substitution Treatment | Morphine | Fentanyl | Methadone

Canada
University of Maryland, Baltimore

Completed

Youth Opioid Recovery Support: Improving Care Systems (YORS)

Opioid-Related Disorders

United States
Universitätsklinikum Hamburg-Eppendorf
Bristol-Myers Squibb

Completed

Interferon-free Antiviral Treatment of Chronic Hepatitis C Virus Infection Among Opioid-substituted Patients (INFO)

Hepatitis C, Chronic | Opioid-Related Disorders

Germany
Haukeland University Hospital
University of Bergen; Helse Stavanger HF; Western Norway University of Applied... and other collaborators

Completed

Physical Activity as Adjunct Treatment for Opioid Substitution Therapy

Substance Use Disorders | Opioid Dependence | Opioid-use Disorder

Norway
University of Cincinnati
National Institute on Drug Abuse (NIDA)

Completed

A Tailored, Peer-delivered Intervention to Reduce Recurring Opioid Overdoses (TTIP-PRO)

Opioid-Related Disorders | Substance Abuse | Drug Overdose | Drug Abuse | Drug Addiction

United States
Duke University
Alkermes, Inc.; Laura and John Arnold Foundation; FHR (Fellowship Health Resources... and other collaborators

Completed

Feasibility Study of Extended-release Naltrexone (Vivitrol) in Drug Court Settings (DC)

Opioid-Related Disorders

United States
HealthPartners Institute
National Institute on Drug Abuse (NIDA); Hennepin Healthcare Research Institute

Completed

Clinical Decision Support for Opioid Use Disorders in Medical Settings: Usability Testing in an EMR (COMPUTE)

Opioid-use Disorder

United States
Saskatchewan Health Authority - Regina Area
Gilead Sciences

Unknown

Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy in Patients With HIV-HCV Co-Infected Subjects on Opioid Substitution Therapy

Hepatitis C, Chronic | HIV/AIDS | Bone Diseases, Metabolic | Opioid Dependence | HIV-1-infection | HCV Coinfection | Buprenorphine Dependence | Methadone Dependence | Co-infection

Canada
National Institute on Drug Abuse (NIDA)

Completed

Treatment of Heroin and Cocaine With Methadone Maintenance and Contingency Management

Cocaine-Related Disorders | Opiate-Related Disorders

United States
University of California, San Francisco
National Center for Advancing Translational Sciences (NCATS)

Completed

EMR Defaults to Nudge Opioid Prescribing

Pain, Acute | Opioid Use, Unspecified
Universitätsklinikum Hamburg-Eppendorf
Asklepios Kliniken Hamburg GmbH; Dr. Rainer Ullmann; Dr. Sibylle Quellhorst; Dr... and other collaborators

Completed

Completion of OST - a Prospective Study

Opioid Dependence
Kaiser Permanente
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine and Substance Abuse Services for Prescription Opioid Dependence

Opiate Substitution Treatment

United States
Lifespan
University of Rhode Island

Completed

Medication Maintenance Therapy in Community Pharmacy Settings (MATPharm)

Opioid-use Disorder

United States
Public Health Management Corporation
Patient-Centered Outcomes Research Institute

Withdrawn

Patient-Centered Care for Opioid Use Disorders in Federally Qualified Healthcare Centers and Specialty Care Settings

Substance Use Disorders | Opioid-use Disorder
Indivior Inc.

Completed

An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery (RECOVER®)

Opioid-use Disorder | Opioid-related Disorders

United States
Cannabis Research Associates

Unknown

Cannabis for Opioid Substitution Trial (COST)

Cannabis Use | Opioid Use | Pain Syndrome

Canada
National Taiwan University

Completed

Efficacy of Drug and Risk Behavior Counseling Intervention Among Injecting Drug Users at Opioid Substitution Treatment

Substance Use Disorders
Montefiore Medical Center
Albert Einstein College of Medicine

Completed

Electronic Defaults to Reduce Opioid Prescribing in Emergency Department and Primary Care Settings

Acute Pain
University Hospital, Basel, Switzerland
University of Basel; Psychiatric Hospital of the University of Basel

Completed

Adherence to Polypharmacy in Patients With Opioid Substitution Therapy Using Electronics (APPOSTEL)

Substance-Related Disorders

Switzerland
University Hospital, Angers

Unknown

Content and Expectations of Consultations of Patients With Opioid Substitution Treatment Considered as Stabilized: Cross-Testimonials Doctors - Patients (MSOSuiStab) (MSOSuiStab)

Opioid Substitution Treatment

France
Butler Hospital

Completed

Treating Chronic Pain in Buprenorphine Patients in Primary Care Settings (BupPain)

Depression | Pain | Substance Use

United States
AiCure
Montefiore Medical Center; Orexo AB

Completed

Using Artificial Intelligence To Monitor Medication Adherence in Opioid Replacement Therapy

Addiction | Opioid Dependence | Opiate Addiction | Medication Non-adherence

United States
University of Pittsburgh
Schering-Plough

Terminated

Pilot Study of IFN α2b for Melanoma Patients

Melanoma

United States
Yale University
National Institute on Drug Abuse (NIDA); APT Foundation, Inc.

Completed

Automated Recovery Line for Medication Assisted Treatment

Substance Use Disorders | Drug Dependence

United States

Search clinical trials for: opioid substitution settings

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kenya

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations